BSEBoard Meeting6d ago · 6 Aug 2026, 06:30 pm

This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 6th August, 2026 (i.e. today), inter-alia, considered and approved the following items: ....

Indraprastha Medical Corporation Ltd · 532150

✦ AI SummaryResults

Indraprastha Medical Corporation Ltd has announced its un-audited financial results for the quarter ended 30th June, 2026, along with the Limited Review Report of the Statutory Auditors. The Board has also approved convening the thirty-eighth Annual General Meeting on 24th September, 2026, and fixed the record date for the purpose of determining the names of shareholders entitled for the dividend for the year 2025-26 and for the Annual General Meeting as 18th September, 2026. Additionally, the Board has approved the re-appointment of M/s Devarajan Swaminathan and Co. as Cost Auditors for the financial year 2026-27.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Outcome for Outcome Of Board Meeting

Attachments (1)

📄

8588c035-cf91-43ea-a9d9-fd074a0b6737.pdf

pdf

Download →
View document text
Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India) Corporate Identity Number : L24232DL1988PLC030958 Phone:91-11-26925858,26925801,Fax: 91-11-26823629 E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/ Ref: IMCL/CS/BM/2026 6th August, 2026 The Manager The Manager Listing Department Listing Department BSE Limited Phiroze Jeejeebhoy National Stock Exchange of India Limite Towers Dalal Street, Mumbai, Exchange Plaza, C-1, Block G, Maharashtra - 400001 Bandra Kurla Complex, Bandra East, Scrip Code: 532150 Mumbai, Maharashtra – 400051 Symbol: INDRAMEDCO Re: Outcome of the Board Meeting held on 6th August, 2026 Dear Sir, This is to inform that the Board of Directors of the Company has, at its meeting held on Thursday, 6th August, 2026 (i.e. today), inter-alia, considered and approved the following items: 1. The Un-audited Financial Results of the Company for the quarter ended 30th June, 2026. Considered and approved the Un-audited Financial Results for the quarter ended 30th June, 2026, along with the Limited Review Report of the Statutory Auditors. We are enclosing herewith the Un-audited Financial Results for the quarter ended 30th June, 2026, along with a copy of the Limited Review Report by the Statutory Auditors of the Company – Annexure 1. The above said documents are being posted on the website of the Company i.e., https://www.apollohospitals.com/delhi. The financial results will also be published in the newspapers, in the format prescribed under Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations). 2. Convening Annual General Meeting Approved convening the thirty-eighth Annual General Meeting (AGM) of the Company, on Thursday, 24th September, 2026, through video conferencing / other audio-visual means. Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India) Corporate Identity Number : L24232DL1988PLC030958 Phone:91-11-26925858,26925801,Fax: 91-11-26823629 E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/ 3. Fixation of Record Date The Board has fixed the record date as Friday, 18th September, 2026, for the purpose of determining the names of the shareholders who are entitled for the dividend for the year 2025-26 and also for the purpose of the Annual General Meeting. 4. Appointment of Cost Auditors The Board, based on the recommendation of the Audit Committee, has approved the Re-appointment of M/s Devarajan Swaminathan and Co. – Cost Accountants, as Cost Auditors of the Company, for the financial year 2026-27. Additional information as required under Regulation 30 of Listing Obligations is enclosed as Annexure 2. The Board meeting commenced at 3.00 p.m. and ended at 4.45 p.m. This is for your information and record. Thanking You, Yours sincerely, For Indraprastha Medical Corporation Limited Priya Ranjan AVP – Corporate Affairs & Legal (Company Secretary & Compliance Officer) Encl.: As above Annexure 1 51-52, Sector 18, Phase-IV, Udyog Vihar, Gurugram, Haryana 122015, India Tel: +91 124 481 4444 Review Report on Unaudited Financial Results To the Board of Directors of Indraprastha Medical Corporation Limited 1. We have reviewed the accompanying Statement of Unaudited Financial Results of Indraprastha Medical Corporation Limited (“the Company”) for the quarter ended 30 June 2026 (“the Statement”), being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (‘the Listing Regulations’). 2. This Statement which is the responsibility of the Company’s management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 ‘Interim Financial Reporting’ (‘Ind AS 34’) prescribed under Section 133 of the Companies Act, 2013 (“the Act”), other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity’, issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Ind AS and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations including the manner in which it is to be disclosed, or that it contains any material misstatement. For S N Dhawan & CO LLP Chartered Accountants Firm Registration No.: 000050N/N500045 Bhaskar Sen Partner Membership No.: 096985 UDIN: 26096985SAKEKX7709 Place: New Delhi Date: 06 August 2026 S N Dhawan & CO LLP is registered with limited liability with identification number AAH-1125 and its registered office is 108, Mercantile House, 15, Kasturba Gandhi Marg, New Delhi 110001, India INDRAPRASMTEHDAI CACLO RPORATILOINM ITED �A Registoeffir:ceS eda rViithaaD re,lM hait huRroaaN de,w D el-h1i1 0076l ndraprastha CorpoIrdaetneNt uimtby:e L r24232DL1988PLC0309A58 e��!.2 Phon9e1:- 11-269258F5a8x9,:1 -21619-2256880213,6 29 ' •' E-maiimlc:l shares@apolWleobhsoihsttpeti:pt sa:l/s/.wcwowm.,a poUohospitals.com/delhi StateomfUe nnatu diFtienda nRceisaufllo ttrsh Q eu aretnedre3 d0J un2e0,2 6 Amou(nRtis n c rore) s. Quaretnedre d Yeaern ded Particulars 30.06.23012.60 3.23002.60 6.23012.50 3.2026 (Unaudit(eAdu)d it(eUdn)a udi(tAeudd)i ted) 1 Revefnruoeom p erations 406.15 364.81 365.061 482.51 2 OLhienrc ome 8.42 7.33 6.90 28.75 3 Totianlc ome 414.57 372.14 371.961 511.26 4 Expenses a)C osotfm atercioanlssu med 70.13 64.30 62.84 256.34 b)E mplobyeenee efixLpse nse 72.96 74.18 64.95 287.60 c)Profescshiaortngoade los c tors 111.15 96.59 97.84 389.39 d)Finacnocset s 1.65 1.49 1.56 6.02 c)Deprecainaadtm ioornl -isation expense 11.76 11.34 10.18 43.63 IO)lheexrp enses 72.10 69.23 66.28 282.26 Toteaxlp enses 33795 317.13 303.651 265.24 5 Probfeifteo xrcee ptioannatdla xi tems 74.82 55.01 68.31 246.02 6 Exceptiitoenmasl - - - - 7 Probfeiftto ar(xeP BT) 74.82 55.01 68.31 246.02 8 Taexx pense CurrLeanxl 19.68 11.51 17.43 57.86 Defertraexd (0.71) 1.80 (0.58) 4.54 9 ProffoiUrt1 p ee riaofdtt ea(rxP AT) 55.85 41.70 51.46 183.62 10O thceorm prehienncsoimvee (iH)emUs1 wailnl olbt er eclasLsopi rfooifreli dot s s 3.00 (1.52) 5.98 1.76 (iIin)colmarexe lattoii tnegUm 1swa itnl olbt er eclastsoified (0.75) 0.38 (1.50) (0.44) proofrli ots s Totoatlhc eorm prehienncsoi(mvNeeeo tft aexx penses) 2.25 (1.14) 4.48 1.32 11T otcaolm prehienncsoifmvoteerh pee riod 58.10 40.56 55.94 184.94 12P aid-ups heaqcruaeip ti(ytF aavlca el Ruse1. 0 /e-ach) 91.67 91.67 91.67 91.67 13R ese(revxecsl Ruedvianlgu Raetsieoranvss e hso)wi nnt he 648.70 audibtaelda snhceoeef pt r eviyoeuasr EarninpPes.rhs a Braesa incDd i lu(lRes-dN. o)At 1 mualised 6.09 4.55 5.6 [Showing first 8,000 characters — download PDF for full document]